Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nephrology

S G Massry1

  • 1University of Southern California School of Medicine, Los Angeles, USA.

JAMA
|June 7, 1995
PubMed
Summary
This summary is machine-generated.

Captopril significantly slowed kidney function decline in diabetic patients. Intensive insulin therapy also helps prevent long-term diabetes complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulin secretion in uremia.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
Same author

Defects in B-cell function and metabolism in uremia: role of parathyroid hormone.

Kidney international. Supplement·2001
Same author

Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy.

Proceedings of the National Academy of Sciences of the United States of America·2000
Same author

Effect of amlodipine therapy on the monoclonal antibody 3G8-induced calcium signal in polymorphonuclear leukocytes of hemodialysis patients.

American journal of nephrology·1999
Same author

Jewish medicine and the University of Padua: contribution of the Padua graduate Toviah Cohen to nephrology.

American journal of nephrology·1999
Same author

Mechanisms through which high glucose concentration raises [Ca2+]i in renal proximal tubular cells.

Kidney international·1998
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026
Same journal

HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

JAMA·2026
Same journal

US Dietary Supplement Use Increasing, Especially in Older Adults.

JAMA·2026
Same journal

Heat Stress From Climate Change Surges Globally.

JAMA·2026
Same journal

Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

JAMA·2026
See all related articles

Area of Science:

  • Nephrology
  • Endocrinology
  • Pharmacology

Background:

  • Diabetic nephropathy is a leading cause of kidney failure in patients with insulin-dependent diabetes mellitus (IDDM).
  • ACE inhibitors like captopril have shown potential in managing diabetic complications.
  • Intensive insulin therapy is crucial for managing IDDM and its associated microvascular issues.

Purpose of the Study:

  • To evaluate the effect of captopril on renal function in patients with IDDM.
  • To assess the role of captopril in preventing the progression of diabetic nephropathy.
  • To highlight the benefits of intensive insulin therapy in managing IDDM complications.

Main Methods:

  • A study involving patients with insulin-dependent diabetes mellitus.
  • Administration of captopril at dosages of 25 mg.

Related Experiment Videos

  • Monitoring of serum creatinine levels to assess kidney function.
  • Comparison of outcomes with intensive insulin therapy.

    • Main Results:

    • Captopril (25 mg) reduced the doubling of serum creatinine levels by 48% in patients with IDDM.
    • Intensive insulin therapy demonstrated a delay in the onset and slowed progression of diabetic nephropathy.
    • Intensive insulin therapy also showed benefits in reducing retinopathy and neuropathy.

    Conclusions:

    • Captopril is effective in slowing the progression of kidney disease in patients with IDDM.
    • Comprehensive management including captopril and intensive insulin therapy is vital for diabetic patients.
    • Early intervention with captopril and optimized glycemic control can prevent severe diabetic complications.